ALBT
Closed
Avalon Globocare Corp.
2.82
+0.04 (+1.44%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.78
Day's Range: 2.6 - 2.88
Send
sign up or login to leave a comment!
When Written:
1.98
Avalon GloboCare Corp. is a publicly traded biotechnology company headquartered in Freehold, New Jersey. The company focuses on developing and commercializing innovative cell-based technologies and therapeutics for various diseases, including cancer, autoimmune disorders, and infectious diseases.
Avalon GloboCare's main business segments include cellular therapy, precision medicine, and clinical diagnostics. The company's cellular therapy segment involves developing and commercializing cell-based therapies for various diseases. The precision medicine segment involves developing and commercializing personalized medicine solutions through genetic testing and data analysis. The clinical diagnostics segment involves developing and commercializing diagnostic tools and tests for various diseases.
Avalon GloboCare has partnerships and collaborations with various academic institutions, research organizations, and biotech companies worldwide. The company's goal is to become a leading player in the global biotechnology industry by developing and commercializing innovative therapies and technologies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Avalon GloboCare's main business segments include cellular therapy, precision medicine, and clinical diagnostics. The company's cellular therapy segment involves developing and commercializing cell-based therapies for various diseases. The precision medicine segment involves developing and commercializing personalized medicine solutions through genetic testing and data analysis. The clinical diagnostics segment involves developing and commercializing diagnostic tools and tests for various diseases.
Avalon GloboCare has partnerships and collaborations with various academic institutions, research organizations, and biotech companies worldwide. The company's goal is to become a leading player in the global biotechnology industry by developing and commercializing innovative therapies and technologies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








